Share on StockTwits

Examworks Group (NASDAQ:EXAM) issued its quarterly earnings data on Tuesday. The company reported $0.09 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.04 by $0.05, ARN reports. The company had revenue of $196.45 million for the quarter, compared to the consensus estimate of $184.52 million. During the same quarter in the prior year, the company posted ($0.08) earnings per share. The company’s quarterly revenue was up 25.8% on a year-over-year basis.

Several analysts have recently commented on the stock. Analysts at Deutsche Bank reiterated a “buy” rating on shares of Examworks Group in a research note on Friday, July 18th. They now have a $40.00 price target on the stock, up previously from $38.00. On the ratings front, analysts at Needham & Company LLC cut their price target on shares of Examworks Group from $43.00 to $38.00 in a research note on Tuesday, June 10th. They now have a “buy” rating on the stock.

Examworks Group (NASDAQ:EXAM) traded up 2.08% during mid-day trading on Tuesday, hitting $32.41. 514,527 shares of the company’s stock traded hands. Examworks Group has a 52-week low of $22.05 and a 52-week high of $38.61. The stock has a 50-day moving average of $31.17 and a 200-day moving average of $32.58. The company’s market cap is $1.249 billion.

ExamWorks Group, Inc (NASDAQ:EXAM) is a provider of independent medical examinations (IMEs), peer and bill reviews, and related services, referred to as IME services or the IME industry.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.